Due to a full schedule of pitches at our Feb. 6th meeting, we are holding this special meeting to consider a fourth company: Cytoagents.
This company, led by NAF Member Teresa Whalen, pitched to BlueTree last week. BlueTree has voted to move forward into due diligence. Because several NAF members attended this pitch, this company can be fast-tracked in our process, skipping the initial screening meeting and going straight to a member meeting vote.
Teresa will present for 15 minutes, followed by 10 minutes of questions. Those on the call will then deliberate for another 10 minutes, and an electronic vote will be emailed and tallied. Only those on the call will be able to vote, so we encourage everyone to join by video conference or call in by phone if you can. The meeting should only last approximately 35 minutes.
To Join this Zoom Video Conference Meeting:
Follow this link: https://zoom.us/j/407849592
Use your computer's audio/mic, or dial in by Phone: +1 646 558 8656
Meeting ID: 407 849 592